Date
23 January 2018
Eerste Antimicrobial Resistance Benchmark gelanceerd
The Dutch Association Innovative Medicines covers the publication of the first Antimicrobial Resistance Benchmark and its key findings.
In this article, the Dutch Association Innovative Medicines presents the results of the Antimicrobial Resistance Benchmark, focusing on the antibiotics in development, public-private cooperation, antibiotic discharge and the role of the members of the Association in curbing AMR.